期刊文献+

慢性肾衰竭继发性甲状旁腺功能亢进合并退缩人综合征的临床分析 被引量:7

Clinical analysis of Shrinking man syndrome resulted from secondary hyperparathyroidism
原文传递
导出
摘要 目的分析慢性肾衰竭继发性甲状旁腺功能亢进(SHPT)合并退缩人综合征(SMS)患者的临床特点及相关性因素。方法选取在我院肾内科住院并行甲状旁腺全切术的SHPT患者70例为研究对象,按身高较发病前是否缩短分为退缩组和非退缩组,收集一般资料,所有患者均行甲状旁腺全切术,检测患者血甲状旁腺激素(PTH)、血磷(P)、血钙(Ca)、碱性磷酸酶(ALP)、成纤维细胞生长因子-23(FGF-23)水平,分析合并SMS的影响因素。结果 70例SHPT患者中共有50例合并SMS,发生率为71.4%;退缩组患者透析龄(t=8.368,P=0.000)、血PTH(t=5.814,P=0.000)、血P(t=3.470,P=0.001)、血ALP(t=7.985,P=0.000)、血FGF-23(t=2.128,P=0.037)水平明显高于非退缩组;相关性分析表明,退缩组患者身高缩短与透析龄(r=0.421,P=0.002)、PTH(r=0.418,P=0.003)、ALP(r=0.596,P=0.000)、FGF-23水平(r=0.875,P=0.000)均呈正相关,与血Ca呈负相关(r=-0.394,P=0.005),而与血P无相关性(r=0.029,P=0.061);术后病理证实SMS患者甲状旁腺组织增生以结节性增生为主。结论 SHPT合并SMS的发生主要与透析龄、血PTH、ALP、Ca及FGF-23水平相关。 Objective To analysis the clinical features and related affective factors of Shrinking man syndrome (SMS) in Secondary hyperparathyroidism (SHPT) patients. Methods Seventy SHPT patients were selected as research objects and all accepted parathyroidectomy. All of the patients were divided into shrinking group and control group according to whether their height shortened. The general information was collected, serum parathyroid hormone (PTH), phosphorus (P), calcium (Ca), alkaline phosphatase (ALP) and fibroblast growth factor-23 (FGF-23) detected, then analysis the affective factors of SMS. Results There were 50 patients with SHPT associated with SMS, the rate was 71.4%. Compared with control group, the dialysis ages (t=8.368, P=0.000), PTH (t=5.814, P=0.000), P (t=3.470, P=0.001), ALP (t=7.985, P=0.000), FGF-23 (t=2.128, P=0.037) in SMS group were significantly higher. The height shorten of SMS patients was positively correlated with dialysis ages (r=0.421, P=0.002), PTH (r=0.418, P=0.003), ALP (r=0.596, P=0.000) and FGF-23 (r=0.875, P=0.000), negatively correlated with serum Ca (r=-0.394, P=0.005), and the height shorten had no correlation with serum P (r=0.029, P=0.061). In addition, pathology analysis showed that in SMS patients the hyperplasia form of parathyroid glands was mostly nodular hyperplasia. Conclusion The affective factors of SMS in SHPT patients are dialysis ages, serum PTH, ALP, Ca and FGF-23.
出处 《中华临床医师杂志(电子版)》 CAS 2013年第23期139-141,共3页 Chinese Journal of Clinicians(Electronic Edition)
关键词 肾功能衰竭 慢性 甲状旁腺功能亢进症 继发性 退缩人综合征 Kidney failure,chronic Hyperparathyroidism,secondary Shrinking man syndrome
  • 相关文献

参考文献14

  • 1于玲,李寒,王世相,申珅.维持性血液透析患者合并退缩人综合征5例临床分析[J].中国血液净化,2011,10(5):239-241. 被引量:24
  • 2Horensten ML,Boner G,Rosenfeld JB. The shrinking man.A manifestation of severe renal osteodystrophy[J].{H}JAMA:the Journal of the American Medical Association,1980.267-268.
  • 3Memmos DE,Eastwood JB,Harris E. The 'shrinking man' syndrome[J].{H}NEPHRON,1982.106-109.
  • 4刘俊.维持性透析病人合并退缩人综合征一例[J].透析与人工器官,1996(1):41-41. 被引量:4
  • 5Yeun JY,Levine RA,Mantadilok V. C-Reactive protein predicts all-cause and cardiovascular mortality in hemo-dialysis patients[J].{H}American Journal of Kidney Disease,2000.469-476.
  • 6Zoccali C. Cardiovascular risk inuraemic patients-is it fully explained by classical risk factors Nephrol[J].{H}Nephrology Dialysis Transplantation,2000.454-457.
  • 7Yoon JW,Pahl MV,Vaziri ND. Spontaneous leukocyte activa-tion and oxygen-free radical generation in end-stage renal disease[J].{H}Kidney International,2007.167-172.
  • 8Morena M,Cristol JP,Bosc JY. Convective and diffusive losses of vitamin C during haemodiafiltration session:a contributive factor to oxidative stress in haemodialysis patients[J].{H}Nephrology Dialysis Transplantation,2002.422-427.
  • 9张建荣;张凌.退缩人综合征的研究进展[J]{H}国际移植与血液净化杂志,20081-3.
  • 10于宗周.血液净化与矿物质代谢[M]{H}武汉:湖北科学技术出版社,198956.

二级参考文献20

  • 1郑宏,赵叶红,张青,张国芳.退缩人综合征一例[J].西北国防医学杂志,1998,19(2):20-20. 被引量:4
  • 2刘俊.维持性透析病人合并退缩人综合征一例[J].透析与人工器官,1996(1):41-41. 被引量:4
  • 3于敬东,邹国红,崔志钧.退缩人综合征附3例报道[J].中国血液净化,2006,5(9):702-702. 被引量:9
  • 4张凌.慢性肾脏病甲状旁腺功能亢进症的病理生理及临床表现//张建荣,张凌.慢性肾脏病继发性甲旁亢[脚.北京:人民军医出版社,2010:82-114.
  • 5Moranne 0, Froissart M, Rossert J, et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol, 2009, 20 : 164-171.
  • 6Goodman WG, Goldin J, Kuizon BD, et al. Coronary-arte~ calcification in young adults with end-stage renal disease who are undergoing dialysis. N Eng J Med,2000,342:1478-1483.
  • 7Teresa A, Joao MF. Cardiovascular risk in dialysis patients : X-ray vision on vascular calfications. Kidney Int, 2008,74:1505-1507.
  • 8Kidney Disease: Improving Global Outcomes (KDIGO) CKD- MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Snpp1,2009 ,'( 113 ) : S1-130.
  • 9Raggi P, Kleerekoper M. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease. Clin J Am Soc Nephrol, 2008,3:836-843.
  • 10Cohen J, Diamond I. Leontiasis ossea, slipped epiphyses, and granulose cell tumor of testis with renal disease. Arch Pathol,1953, 56:488-500.

共引文献50

同被引文献68

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部